Comparing Arndt and Tappa Endobronchial Blocker During Pediatric One Lung Ventilation

A Prospective Randomized Trial Comparing the Application of Arndt and Tappa Endobronchial Blocker During Pediatric One Lung Ventilation

This study aims to evaluate the efficacy and ease of placement of two different endobronchial blockers(Arndt and Tappa blocker) for pediatric patients undergoing thoracotomy. Time from laryngoscopy to successful insertion of the blocker by an experienced anaesthetist will be recorded and the difficulty of placement of the blocker will be assesed. We plan to evaluate the lung collapse and also observe the effect of two different bronchial blockers on patients' ventilation and oxygenation and adverse events such as desaturation, failed one lung ventilation.Our primary outcome is the time from laryngoscopy to successful insertion of the bronchial blocker by an experienced anaesthetist. Our secondary outcomes are effects of two different bronchial blockers on lung isolation score, ease of placement of the bronchial blocker, mechanical ventilation parameters (tidal volume, respiratory rate, peak airway pressure, plateau pressure, compliance), intraoperative blood gas analysis (paO2, pCO2, saO2, lac), frequency of malposition after successful blocker placement, surgical exposure and complications.

Study Overview

• Status: Not yet recruiting
• Conditions: Lung Diseases
• Intervention / Treatment: Device: Tappa Endobronchial Blocker; Device: Arndt Endobronchial Blocker

Detailed Description

Many techniques for one lung ventilation exist including the use of double-lumen tubes, endotracheal tubes and bronchial blockers. The choice of lung isolation technique depends on the age, the size of the patient, experience of the anaesthetist and type of the surgery. The use of double lumen tube for one lung ventilation is very common. However, it may be challenging and hazardous in some cases such as pediatric patients, patients with tracheostomy, difficult airway scenarios. Endobronchial blockers can be used for these cases. Bronchial blockers have high-volume,low-pressure balloons so they are less likely to cause damage to the airway mucosa while achieving a successful lung isolation. Arndt blocker has a low-pressure, high-volume balloon, a multiport airway adapter and a guide loop. On the other hand, Tappa bronchial blocker has an auto inflation balloon, and a high volume low pressure cuff. It also has 'Tappa angle' which is designed as per human anatomy which makes it easier to insert.

In our study, we aim to compare the efficacy and ease of placement of Arndt and Tappa blocker for pediatric one lung ventilation. Our primary outcome is the time from laryngoscopy to successful insertion of the bronchial blocker by an experienced anaesthetist. Secondary outcomes are effects of two different bronchial blockers on lung isolation score, ease of placement of the bronchial blocker, mechanical ventilation parameters (tidal volume, respiratory rate, peak airway pressure, plateau pressure, compliance), intraoperative blood gas analysis (paO2, pCO2, saO2, lac), frequency of malposition after successful blocker placement, surgical exposure and complications. The difficulty of placement of the blocker will be assesed by a 5-point scale (1:very easy, 5:impossible) and the lung collapse will be evaluated by using a 10-point scale (10: complete collapse).

• Study Type: Interventional
• Enrollment (Anticipated): 26
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Meltem Savran Karadeniz, Assoc Prof; Phone Number: 02126318767; Email: mskaradeniz@gmail.com
• Study Contact Backup: Name: Suna Arat, Dr; Phone Number: 05399833797; Email: suna_arat@hotmail.com

Study Locations

• Turkey
  • Istanbul, Turkey
    • Istanbul University
    • Contact: Meltem Savran Karadeniz, Assoc Prof; Phone Number: 02126318767; Email: mskaradeniz@gmail.com
    • Contact: Suna Arat, Dr; Phone Number: 05399833797; Email: suna_arat@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 2 years to 14 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Pediatric patients undergoing thoracic surgery
• American Society of Anesthesiology Class 1-2-3

Exclusion Criteria:

• Denial of patients or parents
• Coagulopathy
• With preexisting cardiac dysfunction
• Wtih history of renal and/or hepatic dysfunction

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Tappa Blocker Group; After orotracheal intubation, Tappa endobronchial blocker will be inserted using a broncoscope by an experienced anaesthetist. Time from laryngoscopy to successful placement of the endobronchial blocker will be recorded.	Device: Tappa Endobronchial Blocker; After intubation, the Tappa bronchial blocker will be advanced either through the intubation tube or outside the tube using a fiberoptic broncoscope. Once the position of the blocker is confirmed, the cuff of the blocker will be inflated with 1-3 mL of air. Since Tappa blocker has an autoinflation system, the anaesthetist can both inflate the cuff with one hand and operate the fiberoptic broncoscope at the same time.
Active Comparator: Arndt Blocker Group; After orotracheal intubation, Arndt endobronchial blocker will be inserted using a broncoscope by the experienced anaesthetist. Time from laryngoscopy to successful placement of the endobronchial blocker will be recorded.	Device: Arndt Endobronchial Blocker; After intubation, the endobronchial blocker will be passed through a multiport airway adapter that is placed at the proximal end of the tracheal tube.The fiberoptic broncoscope will be passed through the port and then through the guidewire loop at the end of the blocker. The bronchial blocker and the broncoscope will be advanced as a single unit into the target part of a right or left lung. The broncoscope will be withdrawn into the trachea and the blocker cuff will be inflated and the position of the blocker will be confirmed using the fiberoptic broncoscope. The wire loop will be removed after correct placement of the blocker. Once the guide wire is removed, the blocker can't be replaced.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time from laryngoscopy to placement of the bronchial blocker	Time from laryngoscopy to correct insertion of the bronchial blocker by an experienced anaesthetist will be recorded.	Up to 30 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Lung collapse score	Lung collapse will be assesed at 5,10,15,and 20 minutes after pleural opening using a 10-point scale by the surgeon. 1 point refers to the inflated lung and 10 point refers to a completely collapsed lung.	Up to 30 minutes
Difficulty of placement	The anaesthetist will rate the difficulty of placement of the bronchial blocker using a 5-point scale, 1 point being very easy and 5 points being impossible to insert.	Up to 30 minutes
Tidal volume	Volume of gas delivered during each ventilator breath.	Up to 120 minutes
Respiratory rate	Number of breaths delivered by the ventilator per minute.	Up to 120 minutes
Peak airway pressure	Pressure used to deliver tidal volume by overcoming resistance in airways and lungs .	Up to 120 minutes
Plateau pressure	End inspiratory pressure during a period with no gas flow in the circuit.	Up to 120 minutes
Compliance	Change in volume of the lung produced by a change in pressure across the lung.	Up to 120 minutes
Partial pressure of oxygen	Measurement of oxygen pressure in arterial blood.	At 15 minutes after initiation of one lung ventilation.
Partial pressure of carbon dioxide	Measurement of carbon dioxide pressure in arterial blood.	At 15 minutes after initiation of one lung ventilation.
Lactate	Lactate levels in arterial blood gas is used to evaluate tissue perfusion.	At 15 minutes after initiation of one lung ventilation.
Frequency of malposition of the bronchial blocker	Frequency of malposition of the bronchial blocker after successful bronchial blocker placement will be recorded if the blocker displaces.	Up to the end of one lung ventilation intraoperatively.
Length of intensive care unit (ICU) stay	If the patients stay in ICU postoperatively	Up to 48 hours
First mobilitisition time	First mobilitisition time	Up to 24 hours
Length of hospital stay	Length of hospital stay	Up to 1 week

Collaborators and Investigators

• Sponsor: Istanbul University
• Investigators: Principal Investigator: Meltem Savran Karadeniz, Assoc Prof, Istanbul University

Publications and helpful links

General Publications

• Baek SY, Kim JH, Kim G, Choi JH, Jeong CY, Ryu KH, Park DH. Successful one-lung ventilation by blocking the right intermediate bronchus in a 7-year-old child: a case report. J Int Med Res. 2019 Jun;47(6):2740-2745. doi: 10.1177/0300060519845782. Epub 2019 May 8.
• Wu C, Liang X, Liu B. Selective pulmonary lobe isolation with Arndt pediatric endobronchial blocker for an infant: A case report. Medicine (Baltimore). 2019 Dec;98(50):e18262. doi: 10.1097/MD.0000000000018262.
• Fabila TS, Menghraj SJ. One lung ventilation strategies for infants and children undergoing video assisted thoracoscopic surgery. Indian J Anaesth. 2013 Jul;57(4):339-44. doi: 10.4103/0019-5049.118539.
• Cay DL, Csenderits LE, Lines V, Lomaz JG, Overton JH. Selective bronchial blocking in children. Anaesth Intensive Care. 1975 May;3(2):127-30. doi: 10.1177/0310057X7500300208.
• Wald SH, Mahajan A, Kaplan MB, Atkinson JB. Experience with the Arndt paediatric bronchial blocker. Br J Anaesth. 2005 Jan;94(1):92-4. doi: 10.1093/bja/aeh292. Epub 2004 Oct 14.

Helpful Links

• Selective pulmonary lobe isolation with Arndt pediatric endobronchial blocker for an infant
• One lung ventilation strategies for infants and children undergoing video assisted thoracoscopic surgery
• Selective bronchial blocking in children
• Experience with the Arndt paediatric bronchial blocker
• Successful one-lung ventilation by blocking the right intermediate bronchus in a 7-year-old child: a case report

Study record dates

Study Major Dates

• Study Start (Anticipated): July 25, 2022
• Primary Completion (Anticipated): December 25, 2022
• Study Completion (Anticipated): October 20, 2023

Study Registration Dates

• First Submitted: June 5, 2022
• First Submitted That Met QC Criteria: June 9, 2022
• First Posted (Actual): June 14, 2022

Study Record Updates

• Last Update Posted (Actual): June 14, 2022
• Last Update Submitted That Met QC Criteria: June 9, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Keywords: Pediatrics; Thoracic Surgery; One lung ventilation; Arndt endobronchial blocker; Tappa endobronchial blocker
• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Lung Diseases
• Other Study ID Numbers: 2021/930

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No